Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Vascular Remodeling in LVAD Patients
NCT06510322Phase 1Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Mar 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ASP-001 in vascular disease (2 arms), sponsored by Montefiore Medical Center. Primary endpoints: Change in Aortic Pulse Wave Velocity at 180 days, Change in Gastrointestinal Angiodysplasia Foci at 180 days and 1 more. Started Mar 2025; status: recruiting.
02
Drugs
ASP-001
03
Conditions
vascular disease
Beyond the preview
Go deeper on NCT06510322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06510322.